CN108685728A - A kind of eye cream and preparation method thereof - Google Patents
A kind of eye cream and preparation method thereof Download PDFInfo
- Publication number
- CN108685728A CN108685728A CN201810705308.4A CN201810705308A CN108685728A CN 108685728 A CN108685728 A CN 108685728A CN 201810705308 A CN201810705308 A CN 201810705308A CN 108685728 A CN108685728 A CN 108685728A
- Authority
- CN
- China
- Prior art keywords
- extract
- eye cream
- phase
- alcohol
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 36
- -1 ascorbic acid glucoside Chemical class 0.000 claims abstract description 28
- 229930182478 glucoside Natural products 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 12
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 11
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 10
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 10
- 235000018597 common camellia Nutrition 0.000 claims abstract description 10
- 150000008131 glucosides Chemical class 0.000 claims abstract description 10
- 240000001548 Camellia japonica Species 0.000 claims abstract description 9
- 108010022355 Fibroins Proteins 0.000 claims abstract description 9
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims abstract description 9
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims abstract description 9
- 229950011318 cannabidiol Drugs 0.000 claims abstract description 9
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 9
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims abstract description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 9
- 229940064064 purslane extract Drugs 0.000 claims abstract description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- 241000727169 Prinsepia utilis Species 0.000 claims abstract description 8
- 241000417365 Ulmus davidiana var. japonica Species 0.000 claims abstract description 8
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 8
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 8
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 8
- 229940074992 chondrus crispus extract Drugs 0.000 claims abstract description 8
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000008439 repair process Effects 0.000 claims abstract description 8
- 230000001804 emulsifying effect Effects 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 14
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 150000002191 fatty alcohols Chemical class 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 7
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 7
- 229920002498 Beta-glucan Polymers 0.000 claims description 7
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 7
- 229920002367 Polyisobutene Polymers 0.000 claims description 7
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 7
- 235000021355 Stearic acid Nutrition 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229960000458 allantoin Drugs 0.000 claims description 7
- 229960000541 cetyl alcohol Drugs 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000003446 ligand Substances 0.000 claims description 7
- MWKFXSUHUHTGQN-UHFFFAOYSA-N n-decyl alcohol Natural products CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 claims description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 7
- 239000008117 stearic acid Substances 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 6
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 6
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 6
- 229940036350 bisabolol Drugs 0.000 claims description 6
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical class CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 5
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 5
- 229940068977 polysorbate 20 Drugs 0.000 claims description 5
- 238000004886 process control Methods 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 230000002040 relaxant effect Effects 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000000474 nursing effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229940060184 oil ingredients Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000013558 reference substance Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000007368 endocrine function Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000030097 organ senescence Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a kind of eye creams and preparation method thereof, the eye cream include camellia flower extract, prinsepia utilis royle oil, cannabidiol, cocoyl glucoside and lauric alcohol, thorn A Gan trees benevolence oil, purslane extract, ascorbic acid glucoside, fibroin, aloe barbadensis Miller leaf extract, moral skin repair, Chondrus crispus extract, Japanese elm root extract, fragrant quick easypro, propylben, glycyrrhiza glabra root extract isoreactivity ingredient, remaining is matrix agent, and each ingredient is made after the mixing that gradually feeds intake at different temperatures.Eye cream of the present invention can improve absorption of the human skin to its active ingredient, the effect of realizing the nursing of releiving to eye part skin, desalinate microgroove, anti-oxidant reparation, slow down aging.
Description
Technical field
The invention belongs to cosmetic fields, and in particular to a kind of eye cream and preparation method thereof.
Background technology
Skin is the maximum organ of human body, and with advancing age, human body has a series of biology in aging course
Change, while the reduction of skin and subcutaneous tissue cell ingredient and the change of immune system.Skin aging mechanism study shows to disappear
Except free radical, improve immune function and adjust endocrine function can effective delaying skin tissue aging.
In human facial skin, eye skin is the most thin skin of human body, while being the most frequent position of activity again, pulls skin
The most place of skin number.During skin aging, the generation of wrinkle and microgroove is main surface.Therefore, it is badly in need of
The eye cream of moisturizing, anti-aging antiallergic sense is moistened in exploitation.And commercially available existing eye cream is pure chemistry constituent mostly, only moisturizing work(
Effect.
Invention content
In view of the defects existing in the prior art, the present invention is from the medicinal efficacy of natural products, provide a kind of eye cream and
Preparation method removes free radical, improves immune function and adjust endocrine function, to delay eye part skin aging, eliminates
Wrinkle and microgroove improve absorption of the human skin to its active ingredient, realize nursing of releiving to eye part skin, desalination microgroove,
The effect of anti-oxidant reparation, anti-aging.
The invention is realized by the following technical scheme:
A kind of eye cream, including following ingredient(Weight percent):A phases:Purified water 39.32-73.58%, natrium adetate 0.05%,
Card wave U20 0.10%, allantoin 0.20%, xanthans 0.10-0.50%, glycerine 5.00%, camellia flower extract 0.10-0.50%, B
Phase:Sucrose Polystearic Acid Esters 1.00-3.00%, vitamin E 0.50-2.00%, dimethyl silicone polymer 3.00%, cetanol
0.10%, tridecanol trimellitate 1.00-3.00%, prinsepia utilis royle oil 0.10-0.20%, dimethyl silicone polymer 3.00%, day
Right fatty alcohol(Hexadeca-octadecyl alcohol, the hexadeca-octadecyl alcohol include hexadecanol, heptadecanol and octadecyl alcolol)0.50-0.80%, diethyl
Base hexyl hexamethylene 2.00%, cannabidiol 0.50-2.00%, cocoyl glucoside and lauric alcohol 0.50-2.5%, thorn A Gan tree benevolence
Oily 0.50-2.5%, C phase:Acrylamide/ammonium acrylate copolymer and polyisobutene and polysorbate -20 0.80%, D phases:Benzene
Oxyethanol and Sensiva SC50 compound ligand 0.50%, 1,2- pentanediols 3.00%, hyaluronic acid(10000 molecular weight)0.05-
0.10%, low-numerator sodium hyaluronate(200000 molecular weight)0.01-0.03%, beta glucan 1.00-5.00%, hexyl decyl alcohol and red
Bisabol and cetyl-PG hydroxyethyl palmitamides and stearic acid and campesterol class 1.00-3.00%, purslane extract
1.00-5.00%, hydrolysis chitin 0.50-2.00%, ascorbic acid glucoside 0.50-1.00%, fibroin 1.00-3.00%,
Aloe barbadensis Miller leaf extract 1.00-3.00%, moral skin repair 0.50-1.00%, Chondrus crispus extract 0.50-1.00%, Japanese elm
Root extract 0.50-1.00%, fragrant quick easypro 0.10-0.50%, propylben 0.20%, glycyrrhiza glabra root extract 0.01-
0.10%。
Preferably, the eye cream includes following ingredient(Weight percent):A phases:Purified water 56.60%, natrium adetate
0.05%, card wave U20 0.10%, allantoin 0.20%, xanthans 0.20%, glycerine 5.00%, camellia flower extract 0.10%, B phases:
Sucrose Polystearic Acid Esters 2.00%, vitamin e1 .50%, dimethyl silicone polymer 3.00%, cetanol 0.10%, the inclined benzene of tridecanol
Three acid esters 2.0%, prinsepia utilis royle oil 0.15%, dimethyl silicone polymer 3.00%, natural fatty alcohol(Hexadeca-octadecyl alcohol, described 16-
Octadecyl alcolol includes hexadecanol, heptadecanol and octadecyl alcolol)0.65%, diethylhexyl hexamethylene 2.00%, cannabidiol 1.50%, coconut palm
Oil base glucoside and lauric alcohol 1.5%, thorn A Gan tree benevolence oil 1.0%, C phases:Acrylamide/ammonium acrylate copolymer and polyisobutene
With polysorbate -20 0.80%, D phases:Phenoxyethanol and Sensiva SC50 compound ligand 0.50%, 1,2- pentanediols 3.00%,
Hyaluronic acid(10000 molecular weight)0.08%, low-numerator sodium hyaluronate(200000 molecular weight)0.02%, beta glucan 3.00%, hexyl
Decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid and campesterol class 2.00%, purslane extract
3.00%, chitin 1.50%, ascorbic acid glucoside 1.00%, fibroin 1.00%, aloe barbadensis Miller leaf extract are hydrolyzed
1.00%, moral skin repaiies 0.50%, Chondrus crispus extract 1.00%, Japanese elm root extract 0.50%, the fragrant quick 0.20%, nipalgin that relaxes
Propyl ester 0.20%, glycyrrhiza glabra root extract 0.05%.
The preparation method of the eye cream, includes the following steps:
(1)It takes the A phase materials of formula ratio to be added in water phase pot, after being heated to 75-80 DEG C, stirs evenly, be pumped into vacuum emulsifying machine
In, heat preservation is spare;
(2)It takes the B phase materials of formula ratio to be added in oil phase pot, after being heated to 80-85 DEG C, stirs evenly, be pumped into vacuum emulsifying machine
In;
(3)Vacuum emulsifying machine, emulsifying 15-20min are opened, C phase materials are added in 80-85 DEG C of process control temp, continue equal
After matter emulsifies 5-10min, start to cool down;
(4)45 DEG C are cooled to, D phase materials are added, continues to stir 35-40min;
(5)It is cooled to 35 DEG C, you can discharging, inspection after the assay was approved can be filling.
The invention has the advantages that:
(1)Cannabidiol can repair nerve system of human body, and with anti-spasm, resisting rheumatoid arthritis, antianxiety, antidepression,
The pharmacological activity such as anti-insomnia, can releive skin after skin takes in human body, it is often more important that have and relieve stress, improve and sleep
Dormancy quality adjusts the effect of immunity so that improve skin quality from inside to outside;
(2)Being rich in purslane extract has a large amount of flavonoids, adrenin, polysaccharide and various vitamins, amino acid
Equal substances can effectively inhibit pruitus, redness, pain effect, and prevent skin allergy to a certain extent;
(3)Fibroin is the natural polymer fibrin extracted from silk, contains 18 kinds of amino acid;It is to tyrosinase
Inhibiting effect, can effectively inhibit the generation of melanin, have the function that skin whitening;In addition, fibroin can also promote
Into collagen synthesis, activating skin cell improves microcirculation, the effect of repairing impaired skin histology, reach anti-ageing smoothing wrinkle;
(4)Camellia flower extract is extracted to Yunnan camellia, wherein containing there are many flavones, polyphenol, Tea Saponin class activity constituents.
Addition has moistening skin-care, anti-aging, anti-inflammatory and white-skinned face function in cosmetics;
(5)Contain leaf Cai containing reed glucoside, isobarbaloin, β-barbaloin, aloe-emodin and aloe in aloe barbadensis Miller leaf extract
Glucoside A, B isoreactivity constituent.Addition aloe barbadensis Miller leaf extract, which has skin histology, in eye cream significantly sterilizes, disappears
Inflammation, antiallergy, softening skin effect, and have strong absorption to ultraviolet light, there is sun-proof function;
(6)Chondrus crispus is a kind of natural seaweed, and principle active component is polysaccharide carrageenan in extract, is had to skin
The effect of removing aging cutin, Firm, moistening and desalinate wrinkle;
(7)Glycyrrhiza glabra root extract is extracted to the stem of glycyrrhiza glabra, and glycyrrhiza glabra extract can go deep into inside skin and keep
High activity effectively inhibits the activity of a variety of enzymes during melanin production, be it is a kind of it is fast, efficient, safe, green it is sun-proof,
Whitening cosmetics additive.Glycyrrhiza glabra extract also has effects that prevent pachylosis and anti-inflammatory, antibacterial simultaneously;
(8)By the synergistic effect of the above natural extracts, it can reach and remove free radical, improve immune function and adjusting
Endocrine function delays eye part skin aging, smoothes away wrinkles and microgroove.
Specific implementation mode
With reference to embodiment, the claim of the present invention is further described in detail, but not structure
At any limitation of the invention, anyone limited number of time made within the scope of the invention as claimed modification, still in the present invention
Claims in.
Embodiment 1
A kind of eye cream, including following ingredient(Weight percent):A phases:Purified water 56.60%, natrium adetate 0.05%, card wave
U20 0.10%, allantoin 0.20%, xanthans 0.20%, glycerine 5.00%, camellia flower extract(The limited public affairs of Shan Yunnan, Yunnan medicine company
Department)0.10%, B phase:Sucrose Polystearic Acid Esters 2.00%, vitamin e1 .50%, dimethyl silicone polymer 3.00%, cetanol
0.10%, tridecanol trimellitate 2.0%, prinsepia utilis royle oil 0.15%, dimethyl silicone polymer 3.00%, natural fatty alcohol(Ten
Six-octadecyl alcolols)0.65%, diethylhexyl hexamethylene 2.00%, cannabidiol 1.50%, cocoyl glucoside and lauric alcohol 1.5%,
The dry tree benevolence oil of Ci A(French SEPPIC companies)1.0%, C phase:Acrylamide/ammonium acrylate copolymer and polyisobutene and poly- mountain
Pears alcohol ester -20(French SEPPIC companies)0.80%, D phase:Phenoxyethanol and Sensiva SC50 compound ligand(Kening Co., Ltd of the U.S.)
0.50%, 1,2- pentanediols 3.00%, hyaluronic acid(10000 molecular weight)0.08%, low-numerator sodium hyaluronate(200000 molecular weight)
0.02%, beta glucan 3.00%, hexyl decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid and rape
Sterols(German SYMRISE companies)2.00%, purslane extract(Bioland companies of South Korea)3.00%, chitin is hydrolyzed(North
Capital and the bio tech ltd Zheng Tang)1.50%, ascorbic acid glucoside 1.00%, fibroin 1.00%, Aloe Barbadensis Miller
Extract 1.00%, moral skin repair 0.50%, Chondrus crispus extract 1.00%, Japanese elm root extract(Bioland companies of South Korea)
0.50%, fragrant quick 0.20%, propylben 0.20%, the glycyrrhiza glabra root extract 0.05% of relaxing.
The preparation method of the eye cream is:
(1)It takes the A phase materials of formula ratio to be added in water phase pot, after being heated to 75 DEG C, stirs evenly, be pumped into vacuum emulsifying machine,
It keeps the temperature spare;
(2)It takes the B phase materials of formula ratio to be added in oil phase pot, after being heated to 80 DEG C, stirs evenly, be pumped into vacuum emulsifying machine;
(3)Vacuum emulsifying machine, emulsifying 15min are opened, C phase materials are added in 80 DEG C of process control temp, continue emulsifying
After 5min, start to cool down;
(4)45 DEG C are cooled to, D phase materials are added, continues to stir 35min;
(5)It is cooled to 35 DEG C, you can discharging, inspection after the assay was approved can be filling.
Embodiment 2
A kind of eye cream, including following ingredient(Weight percent):A phases:Purified water 39.32%, natrium adetate 0.05%, card wave
U20 0.10%, allantoin 0.20%, xanthans 0.50%, glycerine 5.00%, camellia flower extract(The limited public affairs of Shan Yunnan, Yunnan medicine company
Department)0.50%, B phase:Sucrose Polystearic Acid Esters 3.00%, vitamin E 2.00%, dimethyl silicone polymer 3.00%, cetanol
0.10%, tridecanol trimellitate 3.00%, prinsepia utilis royle oil 0.20%, dimethyl silicone polymer 3.00%, natural fatty alcohol(Ten
Six-octadecyl alcolols)0.80%, diethylhexyl hexamethylene 2.00%, cannabidiol 2.00%, cocoyl glucoside and lauric alcohol 2.5%,
The dry tree benevolence oil of Ci A(French SEPPIC companies)2.5%, C phase:Acrylamide/ammonium acrylate copolymer and polyisobutene and poly- mountain
Pears alcohol ester -20(French SEPPIC companies)0.80%, D phase:Phenoxyethanol and Sensiva SC50 compound ligand(Kening Co., Ltd of the U.S.)
0.50%, 1,2- pentanediols 3.00%, hyaluronic acid(10000 molecular weight)0.10%, low-numerator sodium hyaluronate(200000 molecular weight)
0.03%, beta glucan 5.00%, hexyl decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid and rape
Sterols(German SYMRISE companies)3.00%, purslane extract(Bioland companies of South Korea)5.00%, chitin is hydrolyzed(North
Capital and the bio tech ltd Zheng Tang)2.00%, ascorbic acid glucoside 1.00%, fibroin 3.00%, Aloe Barbadensis Miller
Extract 3.00%, moral skin repair 1.00%, Chondrus crispus extract 1.00%, Japanese elm root extract(Bioland companies of South Korea)
1.00%, fragrant quick 0.50%, propylben 0.20%, the glycyrrhiza glabra root extract 0.10% of relaxing.
The preparation method of the eye cream is:
(1)It takes the A phase materials of formula ratio to be added in water phase pot, after being heated to 80 DEG C, stirs evenly, be pumped into vacuum emulsifying machine,
It keeps the temperature spare;
(2)It takes the B phase materials of formula ratio to be added in oil phase pot, after being heated to 85 DEG C, stirs evenly, be pumped into vacuum emulsifying machine;
(3)Vacuum emulsifying machine, emulsifying 20min are opened, C phase materials are added in 85 DEG C of process control temp, continue emulsifying
After 10min, start to cool down;
(4)45 DEG C are cooled to, D phase materials are added, continues to stir 40min;
(5)It is cooled to 35 DEG C, you can discharging, inspection after the assay was approved can be filling.
Embodiment 3
A kind of eye cream, including following ingredient(Weight percent):A phases:Purified water 73.58%, natrium adetate 0.05%, card wave
U20 0.10%, allantoin 0.20%, xanthans 0.10%, glycerine 5.00%, camellia flower extract(The limited public affairs of Shan Yunnan, Yunnan medicine company
Department)0.10%, B phase:Sucrose Polystearic Acid Esters 1.00%, vitamin E 0.50%, dimethyl silicone polymer 3.00%, cetanol
0.10%, tridecanol trimellitate 1.00%, prinsepia utilis royle oil 0.10%, dimethyl silicone polymer 3.00%, natural fatty alcohol(Ten
Six-octadecyl alcolols)0.50%, diethylhexyl hexamethylene 2.00%, cannabidiol 0.50%, cocoyl glucoside and lauric alcohol
0.50%, thorn A Gan trees benevolence oil(French SEPPIC companies)0.50%, C phase:Acrylamide/ammonium acrylate copolymer and polyisobutene
With polysorbate -20(French SEPPIC companies)0.80%, D phase:Phenoxyethanol and Sensiva SC50 compound ligand(Section of the U.S.
Ning companies)0.50%, 1,2- pentanediols 3.00%, hyaluronic acid(10000 molecular weight)0.05%, low-numerator sodium hyaluronate(20 very much
Son amount)0.01%, beta glucan 1.00%, hexyl decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid
With campesterol class(German SYMRISE companies)1.00%, purslane extract(Bioland companies of South Korea)1.00%, shell is hydrolyzed
Polysaccharide(Beijing and the bio tech ltd Zheng Tang)0.50%, ascorbic acid glucoside 0.50%, fibroin 1.00-3.00%,
Aloe barbadensis Miller leaf extract 1.00%, moral skin repair 0.50%, Chondrus crispus extract 0.50%, Japanese elm root extract(South Korea
Bioland companies)0.50%, fragrant quick 0.10%, propylben 0.20%, the glycyrrhiza glabra root extract 0.01% of relaxing.
The preparation method of the eye cream is:
(1)It takes the A phase materials of formula ratio to be added in water phase pot, after being heated to 75 DEG C, stirs evenly, be pumped into vacuum emulsifying machine,
It keeps the temperature spare;
(2)It takes the B phase materials of formula ratio to be added in oil phase pot, after being heated to 80 DEG C, stirs evenly, be pumped into vacuum emulsifying machine;
(3)Vacuum emulsifying machine, emulsifying 20min are opened, C phase materials are added in 80 DEG C of process control temp, continue emulsifying
After 5min, start to cool down;
(4)45 DEG C are cooled to, D phase materials are added, continues to stir 35min;
(5)It is cooled to 35 DEG C, you can discharging, inspection after the assay was approved can be filling.
Both effectiveness experiment:
The measurement of oxidation resistance
Free radical is normal biochemical reaction product in biological normal metabolic processes, under normal conditions, machine interior free yl
Result from elimination in a kind of dynamic balance, when organism is weaker than generative capacity to the elimination ability of free radical, meeting
The normal cell of human body, including skin cleaning are caused to damage, accelerate organ senescence.Active ingredient is to free radical in skin-protection product
Scavenging activity be its important indicator.
It selects DPPH methods to test the external model of radicals scavenging, the absorption peak intensity of 517nm is measured with spectrophotometry
Degree variation, to the oxidation resistance more of the invention with commercially available reference substance.
It chooses two kinds of imports, a kind of domestic production similar product and the present invention and does check experiment, specific test method is as follows:
20mg DPPH are weighed, with absolute ethyl alcohol constant volume in 250mL brown volumetric flasks, obtain the DPPH solution of 80 μ g/mL;
Tri- kinds of reference substances of 0.50g and eye cream of the present invention are accurately weighed respectively, are dissolved with absolute ethyl alcohol, and be quantitatively transferred to 50mL capacity
It is quantitative to scale, as reference substance and test solution solution of the present invention with absolute ethyl alcohol in bottle;
In 10mL colorimetric cylinders ethyl alcohol be added 5.0mL DPPH solution, after be separately added into reference substance and test solution solution of the present invention, then
It is settled to scale with absolute ethyl alcohol, absorbance is surveyed at 517nm wavelength with 1.0cm colorimetric cylinders immediately after mixing, is denoted as Ai, then
Room temperature measures absorbance after 30min is kept in dark place, and is denoted as Aj.Individually take 5.0mL DPPH solution with anhydrous in 10mL colorimetric cylinders
Ethyl alcohol is settled to scale, measures 517nm absorbances, is denoted as Ac.Free radical scavenging activity is calculated as follows(K):
K(%)=[1-(Ai-Aj)/Ac]*100%
In triplicate, take its average value as final result.
The experimental results showed that the present invention is under 0.50g sampling amounts, the clearance rate to free radical is 31.7%, higher than it is commercially available into
Mouthful(28.4% and 1.3%)With it is domestic(20.7%)Reference substance illustrates that this product oxidation resistance is higher than existing commercial product.
Claims (6)
1. a kind of eye cream, including following ingredient, the weight percent of each ingredient are:A phases:Purified water 39.32-73.58%, according to ground
Acid disodium 0.05%, card wave U20 0.10%, allantoin 0.20%, xanthans 0.10-0.50%, glycerine 5.00%, camellia flower extract
0.10-0.50%, B phase:Sucrose Polystearic Acid Esters 1.00-3.00%, vitamin E 0.50-2.00%, dimethyl silicone polymer
3.00%, cetanol 0.10%, tridecanol trimellitate 1.00-3.00%, prinsepia utilis royle oil 0.10-0.20%, poly dimethyl silicon
Oxygen alkane 3.00%, natural fatty alcohol 0.50-0.80%, diethylhexyl hexamethylene 2.00%, cannabidiol 0.50-2.00%, cocounut oil
Base glucoside and lauric alcohol 0.50-2.5%, thorn A Gan tree benevolence oil 0.50-2.5%, C phases:Acrylamide/ammonium acrylate copolymer and
Polyisobutene and polysorbate -20 0.80%, D phases:Phenoxyethanol and Sensiva SC50 compound ligand 0.50%, 1,2- penta 2
Alcohol 3.00%, hyaluronic acid 0.05-0.10%, low-numerator sodium hyaluronate 0.01-0.03%, beta glucan 1.00-5.00%, hexyl
Decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid and campesterol class 1.00-3.00%, purslane
Extract 1.00-5.00%, hydrolysis chitin 0.50-2.00%, ascorbic acid glucoside 0.50-1.00%, fibroin 1.00-
3.00%, aloe barbadensis Miller leaf extract 1.00-3.00%, moral skin repair 0.50-1.00%, Chondrus crispus extract 0.50-
1.00%, Japanese elm root extract 0.50-1.00%, fragrant quick easypro 0.10-0.50%, propylben 0.20%, the extraction of glycyrrhiza glabra root
Object 0.01-0.10%.
2. eye cream according to claim 1, which is characterized in that including following ingredient, the weight percent of each ingredient is:A
Phase:Purified water 56.60%, natrium adetate 0.05%, card wave U20 0.10%, allantoin 0.20%, xanthans 0.20%, glycerine
5.00%, camellia flower extract 0.10%, B phases:Sucrose Polystearic Acid Esters 2.00%, vitamin e1 .50%, dimethyl silicone polymer
3.00%, cetanol 0.10%, tridecanol trimellitate 2.0%, prinsepia utilis royle oil 0.15%, dimethyl silicone polymer 3.00%, day
Right fatty alcohol 0.65%, diethylhexyl hexamethylene 2.00%, cannabidiol 1.50%, cocoyl glucoside and lauric alcohol 1.5%, thorn
A Gan tree benevolence oil 1.0%, C phases:Acrylamide/ammonium acrylate copolymer and polyisobutene and polysorbate -20 0.80%, D
Phase:Phenoxyethanol and Sensiva SC50 compound ligand 0.50%, 1,2- pentanediols 3.00%, hyaluronic acid 0.08%, low molecule are transparent
Matter acid sodium 0.02%, beta glucan 3.00%, hexyl decyl alcohol and bisabolol and cetyl-PG hydroxyethyl palmitamides and stearic acid
With campesterol class 2.00%, purslane extract 3.00%, hydrolysis chitin 1.50%, ascorbic acid glucoside 1.00%, silk
Albumen 1.00%, aloe barbadensis Miller leaf extract 1.00%, moral skin repair 0.50%, Chondrus crispus extract 1.00%, Japanese elm root carries
Take object 0.50%, fragrant quick 0.20%, propylben 0.20%, the glycyrrhiza glabra root extract 0.05% of relaxing.
3. eye cream according to claim 1 or 2, which is characterized in that the natural fatty alcohol is hexadeca-octadecyl alcohol.
4. eye cream according to claim 1 or 2, which is characterized in that the hyaluronic acid is 10,000 molecular weight.
5. eye cream according to claim 1 or 2, which is characterized in that low-numerator sodium hyaluronate is 200,000 molecular weight.
6. the preparation method of eye cream, includes the following steps described in claim 1-5 any one:
(1)It takes A phase materials to be added in water phase pot, after being heated to 75-80 DEG C, stirs evenly, be pumped into vacuum emulsifying machine, heat preservation is standby
With;
(2)It takes B phase materials to be added in oil phase pot, after being heated to 80-85 DEG C, stirs evenly, be pumped into vacuum emulsifying machine;
(3)Vacuum emulsifying machine, emulsifying 15-20min are opened, C phase materials are added in 80-85 DEG C of process control temp, continue equal
After matter emulsifies 5-10min, start to cool down;
(4)45 DEG C are cooled to, D phase materials are added, continues to stir 35-40min;
(5)Be cooled to 35 DEG C to get.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810705308.4A CN108685728A (en) | 2018-07-02 | 2018-07-02 | A kind of eye cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810705308.4A CN108685728A (en) | 2018-07-02 | 2018-07-02 | A kind of eye cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108685728A true CN108685728A (en) | 2018-10-23 |
Family
ID=63851293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810705308.4A Pending CN108685728A (en) | 2018-07-02 | 2018-07-02 | A kind of eye cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108685728A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820744A (en) * | 2019-04-02 | 2019-05-31 | 浙江邦良日用品有限公司 | A cleaning makeup removing skin care wet tissue based on CBD oil formula |
| CN109908033A (en) * | 2019-04-02 | 2019-06-21 | 浙江邦良日用品有限公司 | A Baby Care wet tissue based on CBD oil formula |
| CN110393691A (en) * | 2019-09-01 | 2019-11-01 | 福建省梦娇兰日用化学品有限公司 | A kind of infant's antiallergic moisturiser containing natural plants |
| US11559499B1 (en) * | 2020-07-21 | 2023-01-24 | Greg Lutovsky | Lotion and tinctures containing CBD oil including preparation and use thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474012A (en) * | 2016-12-10 | 2017-03-08 | 珍尔姿（广州）化妆品有限公司 | A kind of both effectiveness eye cream improving eye wrinkle-removing |
| CN106726965A (en) * | 2016-12-26 | 2017-05-31 | 湖南御家化妆品制造有限公司 | Composite skin care product that antiallergic is releived and preparation method thereof |
| CN107468621A (en) * | 2017-09-27 | 2017-12-15 | 杭州梵琳科技有限公司 | Shu Min facial treatment milk and preparation method thereof |
| CN107982080A (en) * | 2017-12-20 | 2018-05-04 | 汉义生物科技（北京）有限公司 | The purposes of cannabidiol or Cannador in whitening product is prepared |
| CN108186405A (en) * | 2018-03-31 | 2018-06-22 | 佛山文森特知识产权服务有限公司 | A kind of air cushion BB frosts for repairing face skin care |
-
2018
- 2018-07-02 CN CN201810705308.4A patent/CN108685728A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474012A (en) * | 2016-12-10 | 2017-03-08 | 珍尔姿（广州）化妆品有限公司 | A kind of both effectiveness eye cream improving eye wrinkle-removing |
| CN106726965A (en) * | 2016-12-26 | 2017-05-31 | 湖南御家化妆品制造有限公司 | Composite skin care product that antiallergic is releived and preparation method thereof |
| CN107468621A (en) * | 2017-09-27 | 2017-12-15 | 杭州梵琳科技有限公司 | Shu Min facial treatment milk and preparation method thereof |
| CN107982080A (en) * | 2017-12-20 | 2018-05-04 | 汉义生物科技（北京）有限公司 | The purposes of cannabidiol or Cannador in whitening product is prepared |
| CN108186405A (en) * | 2018-03-31 | 2018-06-22 | 佛山文森特知识产权服务有限公司 | A kind of air cushion BB frosts for repairing face skin care |
Non-Patent Citations (1)
| Title |
|---|
| BUTTERFLY0801: "JUST BB弹力保湿蜗牛眼霜", 《HTTP://WWW.COSDNA.COM/CHS/COSMETIC_2C4B112683.HTML》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820744A (en) * | 2019-04-02 | 2019-05-31 | 浙江邦良日用品有限公司 | A cleaning makeup removing skin care wet tissue based on CBD oil formula |
| CN109908033A (en) * | 2019-04-02 | 2019-06-21 | 浙江邦良日用品有限公司 | A Baby Care wet tissue based on CBD oil formula |
| CN110393691A (en) * | 2019-09-01 | 2019-11-01 | 福建省梦娇兰日用化学品有限公司 | A kind of infant's antiallergic moisturiser containing natural plants |
| US11559499B1 (en) * | 2020-07-21 | 2023-01-24 | Greg Lutovsky | Lotion and tinctures containing CBD oil including preparation and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108685728A (en) | A kind of eye cream and preparation method thereof | |
| CN110623882A (en) | Whitening and freckle removing mask and preparation method thereof | |
| CN113262194B (en) | Anti-aging antioxidant liposome face cream and preparation method thereof | |
| CN104825382A (en) | Biotechnology skin-whitening cosmetics | |
| EP2262469A1 (en) | Skin care compositions and methods of use thereof | |
| CN107496195A (en) | A kind of recombined human hyaluronic acid compositions and its application in cosmetics | |
| CN106860086B (en) | Anti-aging composition, preparation process thereof and application thereof in cosmetics | |
| CN109998937B (en) | Cosmetic series containing glycerol glucoside (alpha GG) and preparation method thereof | |
| CN107714504A (en) | A kind of same human-like collagen composition and its applied in cosmetics | |
| CN110742842A (en) | Essence composition for delaying skin aging and preparation method thereof | |
| CN103585096A (en) | Essence with functions of activating and tightening skin and preparation method thereof | |
| KR20110091137A (en) | Cosmetic composition comprising the extract of liriodendron tulipifera as active ingredient | |
| CN110772454B (en) | Skin-brightening, moisturizing, soothing and anti-aging compound essential oil, and preparation method and application thereof | |
| CN104414914A (en) | Striae gravidarum recovery essence | |
| CN111631969A (en) | Repair liquid with blue light resisting effect and cosmetic thereof | |
| CN115089536A (en) | Moisturizing cream with anti-aging effect strengthening effect and preparation method thereof | |
| CN113693990A (en) | Composition for effectively resisting oxidation and preserving moisture as well as preparation method and application thereof | |
| CN115517999B (en) | Anti-aging composition and application thereof in beauty and skin care | |
| JP2016510016A (en) | Cosmetic composition containing brown algae extract, yeast extract and ascorbic acid | |
| CN106333880B (en) | toner based on thin emulsion and preparation method thereof | |
| KR101009766B1 (en) | Cosmetic Composition containing the Extract of prunella vulgaris and Artemisia abrotanum for Improvement of Wrinkle | |
| CN114272184A (en) | Polypeptide composition, anti-aging repair eye cream containing polypeptide composition and preparation method of anti-aging repair eye cream | |
| CN104473798A (en) | Pseudo-ginseng skin toner and preparation method thereof | |
| CN111374900A (en) | Rose pigment glycoside skin-care fresh flower water and preparation method thereof | |
| CN110613663A (en) | Skin repairing composition, skin care product and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181023 |